Anticancer agent containing dendritic cell having RNA virus transferred thereinto
US8889118B2 · kind B2 · utility
11Cited by
10References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2005 |
| Grant date | Nov 18, 2014 |
| Priority date | — |
| Expiry date | Dec 17, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18871
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides anticancer agents comprising dendritic cells introduced with RNA viruses. The present invention also provides methods for producing anticancer agents, which comprise the step of preparing dendritic cells introduced with RNA viruses. The present invention also provides methods for treating cancers using dendritic cells introduced with RNA viruses. The present invention provides effective methods for treating cancers, which use RNA viruses and dendritic cells in combination.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.